Tag:

Pfizer

COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season
Covid-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season Now that the new COVID-19 vaccine is available in New York, Gov. Kathy Hochul is urging residents to get their updated shots ahead of this year's respiratory virus illness season. Related story - COVID-19: New XEC Strain 'Just Getting Started' Sparks Concern Amid Summer Wave Of US Cases In an announcement this week, Hochul encouraged eligible New Yorkers to get the new Food and Drug Administration-approved vaccine for the 2024-2025 season, offered by Pfizer, Moderna, and Novavax.  According to Hochul, receiving the new vaccine is more pressing as students return to school and …
FDA Approves Updated COVID-19 Vaccines: Here's When They Will Be Available FDA Approves Updated COVID-19 Vaccines: Here's When They Will Be Available
FDA Approves Updated Covid-19 Vaccines: Here's When They Will Be Available The US Food and Drug Administration has just approved new COVID-19 vaccines.It marks the third time the vaccines from Pfizer and Moderna have been updated to match circulating strains since the original shot. The shots should be available within days, the FDA said in making the announcement Thursday afternoon, Aug. 22. The new vaccines have been updated with a formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID, including hospitalization and death. “Vaccination continues to be the cornerstone of COVID-19 preventi…
COVID-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says COVID-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says
Covid-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says New York Gov. Kathy Hochul is urging residents to receive a new, updated COVID-19 vaccine meant to target a mutated variant of the virus.  The new vaccine, approved by the federal Centers for Disease Control and Prevention on Tuesday, Sept. 12, and previously authorized by the federal Food and Drug Administration, is meant to target a subvariant of Omicron called XBB.1.5, Hochul announced on Wednesday, Sept. 13. The vaccine was developed after the FDA decided to target the subvariant, which is closely related to over 90 percent of all circulating COVID viruses, according to the CD…
COVID-19: FDA Approves Updated Booster Shots Targeting New Variants COVID-19: FDA Approves Updated Booster Shots Targeting New Variants
Covid-19: FDA Approves Updated Booster Shots Targeting New Variants Health officials are one step closer to rolling out updated COVID-19 vaccines just in time for a rise in cases heading into the fall and winter months. The US Food and Drug Administration (FDA) approved new vaccines on Monday, Sept. 11, that are meant to better target currently circulating COVID-19 variants and provide better protection against hospitalization and death, the agency announced. Monday’s move affects vaccines manufactured by Moderna and Pfizer. The updated mRNA vaccines are each approved for people ages 12 and older and are authorized under emergency use for children ages 6 mo…
UPenn Scientists Develop 'Promising' New Flu Vaccine UPenn Scientists Develop 'Promising' New Flu Vaccine
UPenn Scientists Develop 'Promising' New Flu Vaccine Researchers at the University of Pennsylvania are seeing "promising results" in the early testing phases of an experimental mRNA-based influenza vaccine.  In a statement on Friday, Nov. 25, Penn Medicine scientists said initial models suggest the new vaccine "provided broad protection" against "otherwise lethal" strains of the flu.  The experimental jab is powered by the same mRNA technology used in the Pfizer and Moderna COVID vaccines, researchers added.  “The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu st…
COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA
Covid-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA The Food and Drug Administration has authorized the use of updated COVID-19 booster shots targeting the Omicron variant for younger children. The FDA announced the amended emergency use authorization of the bivalent Moderna and Pfizer booster vaccines on Wednesday, Oct. 12. Today, FDA amended the EUA of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. https://t.co/C2Sx5Nkk0R pic.twitter.com/xsPfO2Mek3 — U.S. FDA (@US_FDA) October 12, 2022 The Moderna bivalent booster is autho…
Young Women Sought As Extras For Episode Of 'Marvelous Mrs. Maisel' Filmed In NYC Young Women Sought As Extras For Episode Of 'Marvelous Mrs. Maisel' Filmed In NYC
Young Women Sought As Extras For Episode Of 'Marvelous Mrs. Maisel' Filmed In NYC The popular Amazon Prime show "The Marvelous Mrs. Maisel" is seeking young women to play extras in an upcoming episode shooting in New York City. Actors must be at least 18 years old and will be portraying "upscale society women and uptown girls" in a 1960s Bryn Mawr college reunion scene with Midge Maisel. Here are the requirements: Hair: No fashion colors. No wigs. No weaves. No braids. No undercuts. No ombré or unnatural looking highlights. No roots if hair is colored. Hair must be above the shoulders; it cannot touch the shoulders. If hair touches shoulders, it will need to be cut…
COVID-19: New Booster Shots Targeting Omicron Variant Approved By FDA COVID-19: New Booster Shots Targeting Omicron Variant Approved By FDA
Covid-19: New Booster Shots Targeting Omicron Variant Approved By FDA It’s time to roll up your sleeve and get another COVID-19 vaccine. On Wednesday, Aug. 31, the US Food and Drug Administration (FDA) approved updated versions of COVID booster shots made by Pfizer and Moderna that target the highly contagious BA.5 Omicron subvariant. The updated vaccine boosters are designed to give people broad protection against COVID and can help protect against severe illness, hospitalization, and death, the FDA said in a statement. Pfizer’s modified booster was authorized for people ages 12 and older, while Moderna’s shot was approved for those 18 and up. People who…
PA Trip Canceled As President Joe Biden Tests Positive For COVID-19 PA Trip Canceled As President Joe Biden Tests Positive For COVID-19
PA Trip Canceled As President Joe Biden Tests Positive For Covid-19 President Joe Biden tested positive for COVID-19 on Thursday, July 21, according to White House Press Secretary Karine Jean-Pierre. He was experiencing “mild symptoms” and has begun taking Paxlovid, the Pfizer antiviral drug designed to reduce the severity of the disease. His trip to Wilkes University in Wilkes-Barre, Pennsylvania has evidently been canceled as he “will isolate at the White House and will continue to carry out all of his duties fully during that time. He has been in contact with members of the White House staff by phone this morning, and will participate in his planned…
COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel
Covid-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans. The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the vaccines - which are currently only available for Americans 5 years and older - for younger children. All 21 members of the FDA's Vaccines and Related Biological Products Advisory Committee unanimously voted to a…
COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel
Covid-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans. The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the vaccines - which are currently only available for Americans 5 years and older - for younger children. All 21 members of the FDA's Vaccines and Related Biological Products Advisory Committee unanimously voted to a…
COVID-19: Pop-Up Vaccination Clinic Scheduled In Mount Vernon COVID-19: Pop-Up Vaccination Clinic Scheduled In Mount Vernon
Covid-19: Pop-Up Vaccination Clinic Scheduled In Mount Vernon A pop-up COVID-19 clinic has been scheduled in one of Westchester’s largest communities. #VaxUpWestchester announced that it is teaming up with the Mount Vernon Neighborhood Health Center and RXR Realty to provide COVID-19 vaccinations and boosters for all eligible residents in the region. The event has been scheduled for 10 a.m. through 4 p.m. on Saturday, April 30, at the Food Bazaar on Bogopa Place in Mount Vernon, officials said. As part of the event, there will be a “$50 cash-equivalent gift card available for those receiving a first dose or booster.” Officials said that the event w…
Albany County ‘Strongly Recommends’ Masking Up Indoors Albany County ‘Strongly Recommends’ Masking Up Indoors
Albany County ‘Strongly Recommends’ Masking Up Indoors Health officials in Albany County are calling for a return to mask wearing amid a rise in COVID-19 cases in the area. In a public health advisory issued Monday, April 25, the Albany County Department of Health said it “strongly recommends” all residents, regardless of vaccination status, wear masks in indoor public spaces, including private businesses. The advisory follows a nearly 40% surge in COVID cases in New York in the past week, according to state health officials. Albany and Rensselaer counties are both in the orange or “high” category on a Centers for Disease Control and Preventi…
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer Pills Recalled Due To Increased Cancer Risk
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer has issued a recall for blood pressure pills that were distributed across the United States due to the presence of an organic compound it said could increase the risk of cancer. The five lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level, the Food and Drug Administration announced. "These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time," the FDA sai…
COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication
Covid-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication Stop & Shop has begun offering two approved COVID-19 antiviral medicines, Pfizer's Paxlovid and Merck's Molnupiravir at its 55 New York pharmacies. The mega-supermarket chain made the announcement on Thursday, April 7, that the drugs would be available at no cost with a valid prescription from a health care provider. The COVID-19 anti-viral medication Molnupiravir can be prescribed to those 18 and older, while Paxlovid is authorized for use by adults and children ages 12 and older weighing at least 88 pounds, store officials said. Availability of the anti-viral oral prescript…
COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans
Covid-19: FDA Authorizes Second Booster Shot For This Group Of Americans Federal health officials authorized a second booster shot of both the Pfizer and Moderna COVID-19 vaccines for older Americans. On Tuesday, March 29, the Food and Drug Administration (FDA) announced that a second shot has been approved for Americans who are 50 and older once four months have passed since their initial booster. With the FDA's approval, the decision now falls on Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention (CDC), who is expected to sign off on the additional shot as soon as Tuesday afternoon. The second booster shot had already been …
COVID-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days COVID-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days
Covid-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days The United States Food & Drug Administration is expected to authorize a second COVID-19 booster shot for some Americans within the next few days, according to multiple reports. CNN reported on Saturday, March 26, that sources said the FDA plans to authorize the additional booster shot for people ages 50 and older in the coming days. An anonymous official told The Washington Post that the authorizations for the additional Moderna and Pfizer booster shots could be announced as soon as Tuesday, March 29. CNN reported that the CDC is expected to give a permissive recommendation following F…
Pfizer Recalls Blood Pressure Medicines Over Carcinogen Pfizer Recalls Blood Pressure Medicines Over Carcinogen
Pfizer Recalls Blood Pressure Medicines Over Carcinogen Pfizer announced a nationwide recall of blood pressure medication that could potentially contain cancer-causing carcinogens. The pharmaceutical giant announced that it was recalling certain lots of the blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of elevated levels of a nitrosamine, an impurity that could cause cancer. “Nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables,” Pfizer officials announced. “Everyone is exposed to some level of nitrosamines. These impurities may increase …
COVID-19: Moderna Seeks Approval For Second Booster Shot For All Adults COVID-19: Moderna Seeks Approval For Second Booster Shot For All Adults
Covid-19: Moderna Seeks Approval For Second Booster Shot For All Adults Though the COVID-19 case numbers across the country have either plateaued or are showing improvement, Moderna is now seeking federal approval to administer a second booster shot for adults. Moderna is seeking an amendment of the US Food and Drug Administration’s emergency use authorization for its COVID-19 vaccine to allow for a fourth vaccine to adults 18 and older who have gotten an initial booster. The move by Moderna comes days after Pfizer and BioNTech submitted a similar request for authorization of an additional booster shot, though that vaccine would only be eligible for adults 65 a…
A Life Full But Too Brief: Beloved NJ Firefighter, IT Whiz, Dies At 57 A Life Full But Too Brief: Beloved NJ Firefighter, IT Whiz, Dies At 57
A Life Full But Too Brief: Beloved NJ Firefighter, IT Whiz, Dies At 57 TRIBUTE: The holiday season at the Emerson Fire Department won't be the same without Mark Brackenbury. Little else in town will be, either. The lifelong firefighter died peacefully at his Jersey Shore home surrounded by loved ones on Sunday, March 13, following a battle with cancer. He was 57. A Queens native, Brackenbury earned bachelor's and master's degrees from Stevens Institute of Technology in Hoboken before becoming an accomplished IT director. He began his professional career in 1993 as an IT manager with Health Management Systems in New York before joining Pfizer in 2002. Bracke…
COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed
Covid-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed Warning that "many variants are coming," the chairman and chief executive officer of Pfizer says a fourth dose of the COVID-19 -- a second booster shot -- will be needed. Appearing on CBS-TV's "Face the Nation" on Sunday, March 13, Dr. Albert Bourla was asked if a COVID booster shot could become recommended each fall - similar to a flu shot. "I think so," Bourla responded. "And I think this is what we are trying now to make." Bourla said Pfizer is trying "very diligently to stay ahead of the virus" because "many variants are coming and Omicron was the first one that was able to evade in a …
COVID-19: Hundreds Of Vaccine Doses Improperly Stored At CT Health Department COVID-19: Hundreds Of Vaccine Doses Improperly Stored At CT Health Department
Covid-19: Hundreds Of Vaccine Doses Improperly Stored At CT Health Department Hundreds of Connecticut residents who recently received a COVID-19 vaccine may have to come back for seconds after a health department improperly stored the doses. The New Haven Department of Health announced on Friday, Feb. 11 that approximately 650 individuals over the age of 12 who received a Pfizer vaccine from the site on Meadow Road may have received doses that were stored for too long, making them less effective in fighting off the virus. Anyone who got the shot between Dec. 23, 2021, and Monday, Feb. 7 at 54 Meadow St. in New Haven may have received the improper vaccine. The Health…
COVID-19: FDA Changes Course On Vaccine Authorization For Kids Under 5 COVID-19: FDA Changes Course On Vaccine Authorization For Kids Under 5
Covid-19: FDA Changes Course On Vaccine Authorization For Kids Under 5 Federal health officials delayed a planned public meeting to review Pfizer’s COVID-19 vaccine for children under five. Citing the need to see more data as part of its rolling application process, the Food and Drug Administration (FDA) announced on Friday, Feb. 11 that it would be delaying the planned meeting, raising questions about how soon children should get the COVID-19 shot. The FDA’s outside experts had been set to meet on Tuesday, Feb. 15 to discuss if children under the age of 5 could safely receive a low dose of the vaccine safely. Pfizer said on Friday that it will be waiting fo…
COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say
Covid-19: Johnson & Johnson Pauses Vaccine Production, Reports Say The only Johnson & Johnson facility currently making viable batches of the company's one-dose COVID-19 vaccine has temporarily halted its production, according to a new report. According to The New York Times, Johnson & Johnson has stopped production of its current vaccine, potentially to create a more profitable version aimed at other viruses. With production on hold at its Dutch facility in the city of Leiden, hundreds of millions of doses could be taken out of circulation, though it is unclear how vaccine supplies in the US have been affected. Ayoade Alakija, a co-head of the A…
COVID-19: Pfizer Asks FDA For Emergency Use Authorization Of Vaccine For Children Under 5 COVID-19: Pfizer Asks FDA For Emergency Use Authorization Of Vaccine For Children Under 5
Covid-19: Pfizer Asks FDA For Emergency Use Authorization Of Vaccine For Children Under 5 New York-based Pfizer and its European partner BioNTech has requested that the Food and Drug Administration (FDA) expand the use of its COVID-19 vaccine to include children between the ages of 6 months and 5 years old, officials announced. On Tuesday, Feb. 1, citing a host of clinical trials, the pharmaceutical company announced it is seeking emergency use authorization (EUA) to admit the vaccine to a wider range of children. Currently, the vaccine is only approved for children 5 years old and older. Pfizer said that it plans to complete its EUA submission “in the coming days,” and has alre…
COVID-19: Moderna Vaccine Gets Full Approval From FDA COVID-19: Moderna Vaccine Gets Full Approval From FDA
Covid-19: Moderna Vaccine Gets Full Approval From FDA Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use. On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago. The move comes after tens of millions of doses of the Moderna vaccine have already been administered across the country. It also represents Moderna’s first FDA-approved product in the US. Officials said the FDA reviewed months of additional follow-up data submitted by Moderna to…
COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant
Covid-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant New York-based Pfizer and its European partner BioNTech have launched a clinical study to evaluate a COVID-19 vaccine that specifically targets the Omicron variant. The study will evaluate the safety and efficacy of an Omicron-based vaccine among healthy adults ages 18 through 55, Pfizer announced on Tuesday, Jan. 25. According to a recent update from the Centers for Disease Control and Prevention (CDC), the Omicron variant is estimated to have accounted for 99.5 percent of circulating variants of COVID-19 in the United States between Sunday, Jan. 9, and Saturday, Jan. 15. Pfizer said up t…
COVID-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready COVID-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready
Covid-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready A vaccine targeting the highly transmissible Omicron COVID-19 variant could be on the way from Pfizer. On Monday, Jan. 10, Pfizer CEO Albert Bourla said that booster targeting Omicron will be ready as soon as March, as the company has already begun ramping up production of the doses. “This vaccine will be ready in March,” Bourla told CNBC’s “Squawk Box.” “We (are) already starting manufacturing some of these quantities at risk.” Related story - COVID-19: Fauci Offers New Prediction On When Omicron Wave May Break The vaccine will not exclusively target Omicron, but will also be able to fig…
COVID-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket COVID-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket
Covid-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket As the Omicron COVID-19 variant rages across the country, federal health officials have expanded the eligibility for booster shots in younger Americans. The Food and Drug Administration (FDA) announced on Monday, Jan. 3 that it is expanding the eligibility for Pfizer and BioNTech booster shots to American between the ages of 12 and 15 years old as children return to school amid a surge of new COVID-19 infections. FDA vaccine chief Dr. Peter Marks said in a statement the agency made its decision because a booster “may help provide better protection against both the delt…
COVID-19: FDA Authorizes Second Antiviral Pill COVID-19: FDA Authorizes Second Antiviral Pill
Covid-19: FDA Authorizes Second Antiviral Pill For the second time in as many days, the Food and Drug Administration (FDA) has authorized the use of an antiviral pill to treat mild and moderate COVID-19 cases. On Thursday, Dec. 23, the FDA approved the use of Merck’s molnupiravir pill for emergency use authorization, a day after officials authorized the use of Pfizer’s COVID-19 treatment pill. Earlier story - COVID-19: FDA OKs First Authorized Home Treatment For Virus Merck’s pill has been cleared for use by adults 18 and older who have tested positive for COVID-19 and are at the greatest risk of being hospitalized or dying from t…
COVID-19: FDA OKs First Authorized Home Treatment For Virus COVID-19: FDA OKs First Authorized Home Treatment For Virus
Covid-19: FDA OKs First Authorized Home Treatment For Virus The fight against COVID-19 took a step forward as federal health officials authorized the first pill that Americans will be able to take at home to head off the worst effects of the virus. On Wednesday, Dec. 22, the US Food and Drug Administration (FDA) granted emergency authorization for Pfizer’s COVID-19 treatment pill, which has been recommended for people at high risk of developing severe cases of COVID-19. The pill could be available as soon as this weekend, according to Pfizer CEO Albert Bourla. Related story - COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effective…